Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency
Titel:
Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency
Auteur:
Bergman, Peter Wullimann, David Gao, Yu Wahren Borgström, Emilie Norlin, Anna-Carin Lind Enoksson, Sara Aleman, Soo Ljunggren, Hans-Gustaf Buggert, Marcus Smith, C. I. Edvard